Danielle Rubin has a diverse background in engineering, economics, and healthcare. She obtained her Bachelor's and Master's degrees in Bioengineering at the University of Pennsylvania, where she graduated with honors. Rubin is an accomplished director of Translational Science and Business Operations at VantAI, a successful startup that focuses on AI in drug discovery. Previously, she served as a principal at Roivant Health, where she worked with entrepreneurs, scientific research teams, and technology experts to identify and build innovative health solutions. Other companies where she gained professional experience include McKinsey & Company, Deloitte, Ethicon, Inc., and Johnson & Johnson. Rubin's expertise lies in business analysis, project management, research, and development in surgical care, quality operations, and medical devices & diagnostics global supply chain.